Results for tag: "Rhabdomyosarcoma Drug"

Rhabdomyosarcoma is a rare type of cancer that affects the skeletal muscles. It is the most common soft tissue sarcoma in children, and is typically treated with a combination of chemotherapy, radiation, and surgery. Oncology drugs are used to treat cancer, and the Rhabdomyosarcoma drug market is a subset of the larger oncology drug market. The Rhabdomyosarcoma drug market is composed of a variety of drugs, including chemotherapy agents, targeted therapies, and immunotherapies. These drugs are used to treat the disease, as well as to reduce the side effects of treatment. Additionally, supportive care drugs are used to manage symptoms and improve quality of life. The Rhabdomyosarcoma drug market is highly competitive, with many companies developing and marketing drugs for the treatment of this disease. Some of the companies in the market include Novartis, Pfizer, Merck, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more